Literature DB >> 29071273

Chronic Lymphocytic Leukaemia/ Small-Cell Lymphocytic Lymphoma of the Lacrimal Sac: A Case Series.

Yamini Krishna1, Luciane D Irion2, Sozan Karim3, Aruna Dharmsena4, Austin McCormick5, Sarah E Coupland1,3.   

Abstract

BACKGROUND: Lymphomas of the lacrimal sac are rare, accounting for less than 10% of lacrimal sac malignant tumours. They may present with symptoms typical of secondary acquired nasolacrimal duct obstruction and are thus often misdiagnosed.
METHODS: Case series and literature review.
RESULTS: Herein we describe 3 cases of chronic lymphocytic leukaemia (CLL)/small-cell lymphocytic lymphoma (SLL) of the lacrimal sac with immunohistochemical and in 1 case molecular confirmation.
CONCLUSION: Lymphomas of the lacrimal sac should be suspected in patients with known CLL presenting with epiphora and dacryocystitis. During dacryocystorhinostomy, an incisional biopsy of the lacrimal sac is essential for confirming CLL/SLL involvement and may guide treatment.

Entities:  

Keywords:  Chronic lymphocytic leukaemia; Dacryocystitis; Epiphora; Lacrimal sac; Lymphoma

Year:  2017        PMID: 29071273      PMCID: PMC5649339          DOI: 10.1159/000455148

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  10 in total

1.  Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

Authors:  C Auw-Haedrich; S E Coupland; A Kapp; A Schmitt-Gräff; R Buchen; H Witschel
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Malignant lacrimal sac tumors.

Authors:  A Montalban; B Liétin; C Louvrier; M Russier; J-L Kemeny; T Mom; L Gilain
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2010-10-29       Impact factor: 2.080

3.  Lymphoma of the ocular adnexa: A study of 353 cases.

Authors:  Judith A Ferry; Claire Y Fung; Lawrence Zukerberg; Mark J Lucarelli; Robert P Hasserjian; Frederic I Preffer; Nancy L Harris
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

4.  Primary lymphoma of nasolacrimal drainage system: a case report and literature review.

Authors:  Hong-Wei Gao; Herng-Sheng Lee; Yaoh-Shiang Lin; Lai-Fa Sheu
Journal:  Am J Otolaryngol       Date:  2005 Sep-Oct       Impact factor: 1.808

5.  Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study.

Authors:  L D Sjö; E Ralfkiaer; B R Juhl; J U Prause; T Kivelä; C Auw-Haedrich; F Bacin; M Carrera; S E Coupland; B Delbosc; N Ducrey; B Kantelip; J L Kemeny; P Meyer; N C Sjö; S Heegaard
Journal:  Br J Ophthalmol       Date:  2006-05-03       Impact factor: 4.638

6.  Dacryocystitis associated with malignant lymphoma of the lacrimal sac.

Authors:  J W Karesh; K I Perman; M M Rodrigues
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

7.  Involvement of the lacrimal drainage system by leukemia or lymphoma.

Authors:  Chee-Chew Yip; George B Bartley; Thomas M Habermann; James A Garrity
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2002-07       Impact factor: 1.746

8.  Management of lacrimal sac tumours.

Authors:  D N Parmar; G E Rose
Journal:  Eye (Lond)       Date:  2003-07       Impact factor: 3.775

9.  Lacrimal drainage obstruction from lacrimal sac infiltration by lymphocytic neoplasia.

Authors:  R S Benger; B R Frueh
Journal:  Am J Ophthalmol       Date:  1986-02-15       Impact factor: 5.258

10.  Nasolacrimal duct obstruction caused by lymphoproliferative infiltration in the course of chronic lymphocytic leukemia.

Authors:  Ralph Litschel; Marco Siano; Abel-Jan Tasman; Sergio Cogliatti
Journal:  Allergy Rhinol (Providence)       Date:  2015-01
  10 in total
  2 in total

1.  Lacrimal sac lymphoma: a case series and literature review.

Authors:  Feng-Xi Meng; Han Yue; Yi-Qun Yuan; Rui Zhang; Yi-Fei Yuan; Ying-Wen Bi; Jiang Qian
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

2.  Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.

Authors:  Almantas Makselis; Donatas Petroska; Aiste Kadziauskiene; Ruta Jaruseviciene; Andrius Ruzgys; Andrius Cimbalas; Justinas Besusparis; Rimvydas S Asoklis
Journal:  BMC Ophthalmol       Date:  2022-01-05       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.